No Data
No Data
Express News | Jingye Asia Vets: Shareholder intends to inquire about the transfer of 1.5% of the company's shares.
Jingye Asia Vets (688290): Performance affected by impairment drag, normal progress in nuclear and non-nuclear business.
Performance was below expectations due to credit impairment losses. The company released its Q3 report on October 23, with revenue of 0.149 billion yuan from Q1 to Q3 2024, +15.66% year-on-year, and a net income of 7.06 million yuan, +255% year-on-year.
Jingye Asia Vets (688290): Profit improvement in the third quarter of 2024, Nuclear Industry & Global Strategy synchronously exerting efforts.
The performance in the third quarter of 2024 meets our expectations. The company released the performance for 2024Q3: revenue of 0.149 billion yuan (+15.7% year-on-year), net income attributable to shareholders of 7.06 million yuan (+255% year-on-year), in line with our expectations.
Jingye Intelligence: Jingye Intelligence Report for the Third Quarter of 2024
Jingye Intelligence Report for the Third Quarter of 2024
Asia Vets (688290.SH) released the performance for the first three quarters, with a net income of 7.06 million yuan, a year-on-year increase of 255.38%.
Jingye Asia Vets (688290.SH) disclosed the third quarter report for 2024, during the reporting period, the company achieved a revenue of 1.4...